Gong Zheng meets with Rong Haige, Chairman of the Board of Directors of Denmark Novo Nordisk Company.

Today, the Mayor of Shanghai Gong Zheng met with the Chairman of the Board of Directors of Novo Nordisk, Mr. Lars Fruergaard Jorgensen, and his delegation. Gong Zheng said that Shanghai will continue to enhance the innovative capabilities of the biopharmaceutical industry, deepen the international development of the industry, and accelerate the creation of a globally influential innovation hub for the biopharmaceutical industry. He welcomed world-renowned companies like Novo Nordisk to actively participate, continuously improve their headquarters level in Shanghai, deeply integrate into local research and supply chains, empower local companies and medical research institutions in Shanghai, assist in the development of the biopharmaceutical industry in Shanghai, and achieve win-win cooperation. At the same time, he welcomed Novo Nordisk to actively participate in the Eighth CIIE. Shanghai will continue to create a market-oriented, rule of law-based, and international first-class business environment, providing better conditions for the development of various business entities.